Portal de Periódicos da CAPES

Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma

2006; Wiley; Volume: 47; Issue: 2 Linguagem: Italiano

10.1002/pbc.20780

1545-5017

Moshe D. Bell,

Renal and related cancers

Pediatric Blood & CancerVolume 47, Issue 2 p. 228-228 Letter to the Editor Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma Moshe D. Bell MD, Corresponding Author Moshe D. Bell MD [email protected] Division of Hematology/Oncology, The Children's Hospital at Montefiore, Bronx, New YorkDivision of Hematology/Oncology, The Children's Hospital at Montefiore, 3415 Bainbridge Avenue, Bronx, NY 10467.===Search for more papers by this author Moshe D. Bell MD, Corresponding Author Moshe D. Bell MD [email protected] Division of Hematology/Oncology, The Children's Hospital at Montefiore, Bronx, New YorkDivision of Hematology/Oncology, The Children's Hospital at Montefiore, 3415 Bainbridge Avenue, Bronx, NY 10467.===Search for more papers by this author First published: 02 March 2006 https://doi.org/10.1002/pbc.20780Citations: 18Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume47, Issue2August 2006Pages 228-228 RelatedInformation